AUG 25, 2015 11:36 PM PDT

Tumor-Suppressing Protein

Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have led an international group of researchers in establishing the structure of a tumor suppressing protein, PTEN, according to a press release from Carnegie Mellon, as reported in Bioscience Technology. Their findings provide new insights into how the protein regulates cell growth and how mutations in the gene that encodes the protein can lead to cancer. Their findings are published online in Structure, and will appear in the October 6 issue.
Phosphatase and tensin homolog (PTEN), a known tumor suppressing protein, is encoded by the PTEN gene. When PTEN is expressed normally, it acts as an enzyme at the cell membrane, triggering a complex biochemical reaction that regulates the cell cycle and keeps cells from growing or dividing in an unregulated manner. Every cell in the body has two copies of the PTEN gene, one from each parent. If there is a mutation in one or both of the PTEN genes, it interferes with the protein’s enzymatic activity and interferes with its tumor suppressing ability.
An activated PTEN dimer that contains two non-mutant proteins (A) can transform the functional lipid (D) on the cellular membrane (E) into a chemical form that tunes down cancer predilection. Dimers that contain a mutated protein (B) or PTEN monomers cannot transform the functional lipid. 
According to Lösche, who seeks to understand the structure and function of cell membranes and membrane proteins, “Membrane-incorporated and membrane-associated proteins like PTEN make up one-third of all proteins in our body. Many important functions in health and disease depend on their proper functioning. Despite PTEN’s importance in human physiology and disease, there is a critical lack of understanding of the complex mechanisms that govern its activity.”
Researchers led by Pier Paolo Pandolfi at Harvard Medical School recently discovered that PTEN’s tumor suppressing activity gets elevated when two copies of the protein bind together, forming a dimeric protein. Lösche, a professor of physics and biomedical engineering at Carnegie Mellon, believes that PTEN dimerization could help researchers to understand an individual’s susceptibility for PTEN-sensitive tumors. To reveal the way in which dimerization improves PTEN’s ability to stop tumor development, researchers needed to determine the protein’s dimeric structure. Protein structure is usually identified with crystallography, but attempts to use that method with the PTEN dimer had been unsuccessful.

Lösche’s group used small-angle X–ray scattering (SAXS) to gains information about protein structure by scattering X-rays through a solution containing the protein. The researchers used computer modeling to establish the dimer’s structure. They discovered that in the PTEN dimers, the C-terminal tails of the two proteins might bind the protein bodies in a cross-wise way, making them more stable. Thus, they can interact more efficiently with the cell membrane, regulate cell growth and restrain tumor formation. With more knowledge about the structure of the PTEN dimer, researchers can use molecular biology tools to study the atomic-scale mechanisms of tumor formation facilitated by PTEN mutations. They hope that their findings will provide a new direction for cancer therapeutics.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 20, 2018
NOV 20, 2018
Mutations Mutations Which Ones Do We Want?
A team at UCSF makes use of new SLICE tool to generate mutations that reveal specific genetic functions....
DEC 11, 2018
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
DEC 11, 2018
Genetics & Genomics
DEC 11, 2018
Dust with High Levels of Triclosan has More Antibiotic Resistance Genes
Researchers have found that some dust contains high amounts of a common antimicrobial agent called triclosan....
DEC 17, 2018
Health & Medicine
DEC 17, 2018
A Migraine Associated Specific Mutation Increases Neuronal Excitability
One subtype of K2P channel expressed in sensory neurons, TRESK has been reported to play a role in MA in its truncated from TRESK-MT....
JAN 03, 2019
JAN 03, 2019
Genetic Risk Factors Make Some People Susceptible to Common Microbes
Th mycobacteria family of microbes includes over 70 members, which are everywhere and are often harmless. But they make some people sick....
JAN 05, 2019
JAN 05, 2019
Photorespiration Shortcut Boosts Crop Yield
Most crops on earth don't photosynthesize efficiently; they sometimes use a wasteful cellular pathway called photorespiration....
Loading Comments...